Autori: Odanovic O
| Naslov | Determing factors that influence Vedolizumab Response in Inflammatory Bowel Diseases: A Prospective Study (Meeting Abstract) |
| Autori | Knezevic Tamara Dobrosavljevic A Odanovic O Sreckovic S Kralj Djordje Mitrovic M Svorcan Petar V Markovic S |
| Info | JOURNAL OF CROHNS & COLITIS, (2024), vol. 18 br. , Suppl. 1, str. I1550-I1550 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
| Naslov | Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients (Meeting Abstract) |
| Autori | Markovic S Kralj Djordje Odanovic O Homsek Ana B Kalaba Ana Svorcan Petar V Vucicevic Katarina M |
| Info | JOURNAL OF CROHNS & COLITIS, (2023), vol. 17 br. , Suppl. 1, str. 925-925 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa |
| Naslov | Immunity in patients with inflammatory bowel disease on biologic therapy after COVID, 19 vaccination (Meeting Abstract) |
| Autori | Knezevic Tamara Cujic Danica Odanovic O Kralj Djordje Gnjatovic Marija Lj Kalaba Ana Vrinic-Kalem Dusica Svorcan Petar V Markovic S |
| Info | JOURNAL OF CROHNS & COLITIS, (2022), vol. 16 br. , Suppl. 1, str. I349-I349 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
| Naslov | Immunity in patients with inflammatory bowel disease on biologic therapy after COVID, 19 vaccination (Meeting Abstract) |
| Autori | Knezevic Tamara Cujic Danica Odanovic O Kralj Djordje Gnjatovic Marija Lj Kalaba Ana Vrinic-Kalem Dusica Svorcan Petar V Markovic S |
| Info | JOURNAL OF CROHNS & COLITIS, (2022), vol. 16 br. , Suppl. 1, str. I349-I349 |
| Ispravka | ISI/Web of Science Elečas Rang časopisa Citati: ISI/Web of Science |
